Literature DB >> 31312240

Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Rochella A Ostrowski1, Sheela Metgud1, Rodney Tehrani1, Walter M Jay2.   

Abstract

In recent years, the search for the cause of giant cell arteritis (GCA) has led investigators to look to varicella zoster virus (VZV) as the answer. In some ways, the nature of VZV infection makes it an attractive explanation for the pathology observed in GCA. However, studies to date yield a level of inconsistency that still leaves uncertainty as to whether VZV directly causes GCA, and positive findings have not been successfully reproduced.

Entities:  

Keywords:  Giant cell arteritis; temporal artery biopsy; varicella zoster virus; vasculitis

Year:  2019        PMID： 31312240      PMCID： PMC6620003          DOI： 10.1080/01658107.2019.1604763

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN： 0165-8107


  37 in total

1.  Ophthalmic zoster sine herpete.

Authors:  P Goon; M Wright; C Fink
Journal:  J R Soc Med       Date:  2000-04       Impact factor: 5.344

Review 2.  Neurotropic herpesviruses, neural mechanisms and arteritis.

Authors:  J R Martin; W J Mitchell; D B Henken
Journal:  Brain Pathol       Date:  1990-09       Impact factor: 6.508

3.  Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction.

Authors:  R Alvarez-Lafuente; B Fernández-Gutiérrez; J A Jover; E Júdez; E Loza; D Clemente; J A García-Asenjo; J R Lamas
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

4.  Detection of varicella zoster virus DNA in some patients with giant cell arteritis.

Authors:  B M Mitchell; R L Font
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

5.  No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis.

Authors:  J Helweg-Larsen; B Tarp; N Obel; B Baslund
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

6.  The importance of skip lesions in temporal arteritis.

Authors:  D N Poller; Q van Wyk; M J Jeffrey
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

7.  Infection and temporal arteritis: a PCR-based study to detect pathogens in temporal artery biopsy specimens.

Authors:  Robert J Cooper; Stuart D'Arcy; Maura Kirby; Marwan Al-Buhtori; Mohammad J Rahman; Laura Proctor; Richard E Bonshek
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

8.  Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis.

Authors:  Peter G E Kennedy; Esther Grinfeld; Margaret M Esiri
Journal:  J Neurol Sci       Date:  2003-11-15       Impact factor: 3.181

9.  No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis.

Authors:  Alicia Rodriguez-Pla; Josep A Bosch-Gil; Juan E Echevarria-Mayo; José Rossello-Urgell; Roser Solans-Laque; Pere Huguet-Redecilla; John H Stone; Miquel Vilardell-Tarres
Journal:  J Clin Virol       Date:  2004-09       Impact factor: 3.168

10.  Headaches due to giant cell arteritis following herpes zoster ophthalmicus in an elderly patient.

Authors:  S C Kosa; B R Younge; N Kumar
Journal:  Cephalalgia       Date:  2010-02       Impact factor: 6.292
View more
  9 in total

Review 1.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

Review 2.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

3.  Increased Incidence of Giant Cell Arteritis After Introduction of a Live Varicella Zoster Virus Vaccine.

Authors:  William A Agger; Jake A Deviley; Andrew J Borgert; Cary M Rasmussen
Journal:  Open Forum Infect Dis       Date:  2020-12-30       Impact factor: 3.835

4.  SARS-CoV-2 infection triggering a giant cell arteritis.

Authors:  Núria Riera-Martí; Jorge Romaní; Joan Calvet
Journal:  Med Clin (Engl Ed)       Date:  2021-03-11

5.  No Evidence of Varicella-Zoster Virus Infection in Temporal Artery Biopsies of Anterior Ischemic Optic Neuropathy Patients With and Without Giant Cell Arteritis.

Authors:  Robert M Verdijk; Werner J D Ouwendijk; Robert W A M Kuijpers; Georges M G M Verjans
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

Review 6.  Innate and Adaptive Immunity in Giant Cell Arteritis.

Authors:  Mitsuhiro Akiyama; Shozo Ohtsuki; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  Arteritic Anterior Ischemic Optic Neuropathy in the Course of Giant Cell Arteritis After COVID-19.

Authors:  Urszula Szydełko-Paśko; Joanna Przeździecka-Dołyk; Julia Kręcicka; Rafał Małecki; Marta Misiuk-Hojło; Anna Turno-Kręcicka
Journal:  Am J Case Rep       Date:  2022-01-11

Review 8.  Age as a risk factor in vasculitis.

Authors:  Andrea D Gloor; Gerald J Berry; Jorg J Goronzy; Cornelia M Weyand
Journal:  Semin Immunopathol       Date:  2022-02-09       Impact factor: 11.759

9.  Isolated popliteal artery lesion due to giant cell vasculitis post COVID-19 mRNA vaccine and COVID-19 asymptomatic infection.

Authors:  Roberto Gabrielli; Andrea Siani; Gianluca Smedile; Anna Rita Rizzo; Gennaro De Vivo; Federico Accrocca; Stefano Bartoli
Journal:  Vascular       Date:  2022-10-06       Impact factor: 1.105
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.